Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-12-14
2010-11-09
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S234500, C514S266220, C514S266400, C544S116000, C544S293000
Reexamination Certificate
active
07829566
ABSTRACT:
Quinazolines of the formula Iin whichR, R1, R2, R3, R4and Y have the meaning indicated in Patent Claim1, and their salts or solvates as glycoprotein IbIX antagonists.
REFERENCES:
patent: 3753981 (1973-08-01), Breuer
patent: 3970648 (1976-07-01), Horn
patent: 3973021 (1976-08-01), Horn
patent: 3974277 (1976-08-01), Horn
patent: 4642347 (1987-02-01), Kreft, III
patent: 4952567 (1990-08-01), DeMeyts
patent: 5240940 (1993-08-01), Arnold
patent: 5245036 (1993-09-01), Robey
patent: 5324839 (1994-06-01), Clemence
patent: 5436233 (1995-07-01), Lee
patent: 5478938 (1995-12-01), Clemence
patent: 5598994 (1997-02-01), Olewinski
patent: 5817674 (1998-10-01), Clemence
patent: 5840695 (1998-11-01), Frank
patent: 5885803 (1999-03-01), Bandman
patent: 5906819 (1999-05-01), Kaibuchi
patent: 5932470 (1999-08-01), Frank
patent: 5958944 (1999-09-01), Arita
patent: 5972598 (1999-10-01), Chaudhary
patent: 5977102 (1999-11-01), Himmelsbach
patent: 6004979 (1999-12-01), Clemence
patent: 6153617 (2000-11-01), Bridges
patent: 6184226 (2001-02-01), Chakravarty
patent: 6207148 (2001-03-01), Bandman
patent: 6218410 (2001-04-01), Uehata
patent: 6277989 (2001-08-01), Chakravarty
patent: 6326373 (2001-12-01), Uckun
patent: 6391874 (2002-05-01), Cockerill
patent: 6794389 (2004-09-01), Okana
patent: 6890930 (2005-05-01), Mederski
patent: 2001/0014679 (2001-08-01), Tang
patent: 2001/0044442 (2001-11-01), Uckun
patent: 2002/0025968 (2002-02-01), Pamukcu
patent: 2002/0055514 (2002-05-01), Uckun
patent: 2 135 172 (1905-05-01), None
patent: 2 140 280 (1972-02-01), None
patent: 1 163 910 (2001-12-01), None
patent: 1 174 150 (2002-01-01), None
patent: 1 034 793 (2002-02-01), None
patent: 1 177 796 (2002-02-01), None
patent: WO 95/28387 (1995-10-01), None
patent: WO 96/40142 (1996-12-01), None
patent: WO 97/03069 (1997-01-01), None
patent: WO 98/02438 (1998-01-01), None
patent: WO 99/09986 (1999-03-01), None
patent: WO 99/23113 (1999-05-01), None
patent: WO 99/24440 (1999-05-01), None
patent: WO 99/35132 (1999-07-01), None
patent: WO 99/35146 (1999-07-01), None
patent: WO 99/65908 (1999-12-01), None
patent: WO 00/12497 (2000-03-01), None
patent: WO 00/13497 (2000-03-01), None
patent: WO 00/57914 (2000-10-01), None
patent: WO 01/09134 (2001-02-01), None
patent: WO 02/24666 (2002-03-01), None
patent: WO 02/24667 (2002-03-01), None
patent: WO 02/30465 (2002-04-01), None
patent: WO 02/36577 (2002-05-01), None
patent: WO 02/53143 (2002-07-01), None
Vippagunta, S.R. et. al., “Crystalline solids”, Advanced Drug Delivery Reviews, 2001, vol. 48, pp. 3-26.
Botros et al., Chemical Abstracts, 1988, vol. 109, Abstract #211005n.
Fadeeva et al., Chemical Abstracts, 1987, vol. 107, Abstract #70301a.
Foster et al.: “Pharmacological Rescue of Mutant P53 Conformation A. Function”, Science, vol. 286, Dec. 24, 1999 pp. 2507-2510 XP000891848.
Lee et al. “Discovery of Potent Cyclic GMP Phosphodiesterase Inhibitors . . . ” J. Med. Chem, 1995, vol. 38, No. 18, pp. 3547-3557.
Moshalenko et al., Chemical Abstracts, 1987, vol. 106, Abstract #32975v.
Zhikhareva et al., Chemical Abstracts, 1991, vol. 114, Abstract #95118d.
Zhikhareva et al., Chemical Abstracts, 1985, vol. 102, Abstract # 203929g.
Zhikhareva et al., Chemical Abstracts, 1983, vol. 98, Abstract #16639x.
Zhikhareva et al., Chemical Abstracts, 1982, vol. 96, Abstract #199625t.
Zhikhareva et al., Chemical Abstracts, 1980, vol. 93, Abstract #114434v.
Zhikhareva et al., Chemical Abstracts, 1980, vol. 93, Abstract #204585z.
Barnickel Gerhard
Bernotat-Danielowski Sabine
Cezanne Bertram
Devant Ralf
Dhanoa Daljit
Truong Tamthom N
Wilson James O
LandOfFree
4-amino-quinazolines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4-amino-quinazolines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-amino-quinazolines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4155422